Summary
Massachusetts General Hospital (MGH) is a healthcare service provider that offers diagnostic and therapeutic care services. The hospital provides services such as allergy and immunology; ALS multidisciplinary clinic, anesthesia, critical care and pain medicine; back bay healthcare center, beacon hill primary care, blood donor center, Blum center, primary care-revere, burns center, cancer center, cardiac surgery, cardiology and other services. It also provides palliative care, pathology, patient care services, pediatrics and pediatric surgery; pelvic floor disorders center, physical medicine and rehabilitation service; plastic and reconstructive surgery, primary care, primary care associates, psychiatry, pulmonary and critical care medicine, radiation oncology and radiology services, among others. The hospital also provides research, education and training programs. MGH is headquartered in Boston, Massachusetts, the US.
Massachusetts General Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Massachusetts General Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Massachusetts General Hospital, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Massachusetts General Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Massachusetts General Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
Massachusetts General Hospital, Medical Devices Deals, 2011 to YTD 2017 12
Massachusetts General Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 13
Massachusetts General Hospital, Pharmaceuticals & Healthcare, Deal Details 16
Partnerships 16
Trianni Enters into Agreement with Massachusetts General Hospital 16
Kamada Enters into Partnership with Massachusetts General Hospital 17
Aptuit Enters into Agreement with Massachusetts General Hospital 18
Seres Therapeutics Enters into Agreement with Massachusetts General Hospital 19
Abpro Enters into Co-Development Agreement with Massachusetts General Hospital 20
Boehringer Ingelheim Enters into Research Agreement with Icahn School of Medicine, Massachusetts General Hospital, Scripps Research Institute and Weill Cornell Medicine 21
Cynata Therapeutics Enters into Agreement with Massachusetts General Hospital 23
Sernova Enters into Research Agreement with Massachusetts General Hospital 24
MagnaChip Enters into Research Agreement with MGH and Pohang University for Magnetic Bio-Sensor 25
Aria Neurosciences Enters into Partnership with Massachusetts General Hospital 26
Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery 27
Sanofi Enters Into R&D Agreement With Massachusetts General Hospital For Translational Oncology Research 29
Skinmedica Enters Into R&D Agreement With Massachusetts General Hospital 30
Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 31
ZELTIQ Aesthetics Enters Into Co-Development Agreement With Massachusetts General Hospital 32
Angion Biomedica Enters Into Co-Development Agreement With Duke University And Massachusetts General Hospital 33
Veridex Enters Into Co-Development Agreement With Massachusetts General Hospital 34
Licensing Agreements 35
Editas Medicine Enters into Second Licensing Agreement with Massachusetts General Hospital 35
Editas Medicine Enters into Licensing Agreement with Massachusetts General Hospital 36
Biohaven Pharma Enters into Licensing Agreement with General Hospital 37
Translational Sciences Enters Into Licensing Agreement with Massachusetts General Hospital & Harvard University 38
ProQR Therapeutics Enters into Licensing Agreement with Massachusetts General Hospital 39
Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 40
PTC Therapeutics Enters into Licensing Agreement with Massachusetts General Hospital 41
Columbia Labs Enters into Licensing Agreement for IVR Technology 42
NanoString Technologies Enters Into Option For Licensing Agreement With Massachusetts General Hospital 43
MultiVir Enters into Licensing Agreement with Massachusetts General Hospital 44
RetroSense Therapeutics to Enter into Licensing Agreement with Massachusetts General Hospital 45
AZTherapies Enters into Licensing Agreement with Massachusetts General Hospital 46
Santaris Pharma Enters Into Licensing Agreement With Massachusetts General Hospital 47
Massachusetts General Hospital - Key Competitors 48
Massachusetts General Hospital - Key Employees 49
Massachusetts General Hospital - Locations And Subsidiaries 50
Head Office 50
Other Locations & Subsidiaries 50
Joint Venture 50
Recent Developments 51
Government and Public Interest 51
Jul 26, 2017: Incorporating 12-step Program Elements Improves Substance-use Disorder Treatment in Adolescents 51
Jul 19, 2017: DARPA: Building the Safe Genes Toolkit 53
Jul 14, 2017: Immunosuppression underlies resistance to anti-angiogenic therapy 56
May 31, 2017: Radiation therapy, macrophages improve efficacy of nanoparticle-delivered cancer therapy 58
May 31, 2017: Mass. General researchers show how Shigella survives passage through the gastrointestinal tract 60
May 24, 2017: Brain microenvironment makes HER2-positive breast cancer metastases resistant to treatment 62
May 10, 2017: Molecular imaging reveals mechanism for resistance to immune checkpoint blockade 63
Apr 25, 2017: Enzyme treatment reduces alcohol-induced liver damage in mouse models 65
Apr 20, 2017: Pretreatment HIV, immune activation levels determine their persistence during treatment 67
Feb 07, 2017: Cystinosis Research Foundation Grants Support Scientific Studies on Cell Function, New Treatments and the Quest for a Cure 69
Jan 16, 2017: Protein identified by Mass General team may protect tumor-initiating breast cancer cells 71
Nov 14, 2016: ALS ONE Massachusetts ALS Partnership (MAP) Will Accelerate Treatment and Care in ALS 72
Sep 22, 2016: Kenneth Rainin Foundation Awards Over $3 Million to High-Risk, High Reward Inflammatory Bowel Disease Research Projects 73
Sep 12, 2016: International studies identify 44 novel gene sites associated with hypertension risk 75
Sep 08, 2016: New Vaccination Strategies Successfully Coach Immune System to Make Powerful HIV-Neutralizing Antibodies 76
Aug 16, 2016: MGH researchers identify key elements of cellular response to proteasome dysfunction 78
Aug 08, 2016: Study identifies novel treatment resistance mechanism in BRAF-mutant melanoma 79
Jul 14, 2016: Novel compound has promise for treatment of Huntington's disease 80
Jun 06, 2016: New approach could make bone marrow transplants safer 81
Mar 03, 2016: Regular aspirin use found to protect against overall cancer risk 82
Feb 16, 2016: Some chemotherapy drugs may improve tumor response to immune checkpoint therapy 83
Jan 29, 2016: Proton therapy controls common pediatric brain tumor with fewer long-term side effects 84
Jan 19, 2016: Nanoparticles combine photodynamic and molecular therapies against pancreatic cancer 85
Jan 12, 2016: New NIH awards will support development of therapeutic alternatives to traditional antibiotics 86
Jan 05, 2016: Study finds no increased risk of autism, ADHD with prenatal antidepressant exposure 88
Product News 89
Dec 19, 2016: Topical treatment activates immune system to clear precancerous skin lesions 89
Oct 19, 2016: Bracket Announces New Study for Assessment of Brain Insulin Resistance in Alzheimer’s Disease 90
Oct 18, 2016: The Leukemia & Lymphoma Society Launches Groundbreaking Precision Medicine Approach to Treat Acute Myeloid Leukemia, One of the Deadliest Blood Cancers 91
Jun 10, 2017: Mass. General study finds potential mechanism for BCG vaccine reversal of type 1 diabetes 93
May 31, 2017: Clinical trial investigates Alzheimer's disease drug in people with Down syndrome 94
Mar 14, 2016: Anticancer Drug Restores Hearing in Some Patients with Neurofibromatosis 95
Other Significant Developments 97
Feb 23, 2016: Upland Software Helps Healthcare Clients Effectively Plan and Manage Project Workloads 97
Appendix 98
Methodology 98
About GlobalData 98
Contact Us 98
Disclaimer 98
List of Tables
Massachusetts General Hospital, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Massachusetts General Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Massachusetts General Hospital, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Massachusetts General Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Massachusetts General Hospital, Deals By Therapy Area, 2011 to YTD 2017 10
Massachusetts General Hospital, Medical Devices Deals, 2011 to YTD 2017 12
Massachusetts General Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 13
Trianni Enters into Agreement with Massachusetts General Hospital 16
Kamada Enters into Partnership with Massachusetts General Hospital 17
Aptuit Enters into Agreement with Massachusetts General Hospital 18
Seres Therapeutics Enters into Agreement with Massachusetts General Hospital 19
Abpro Enters into Co-Development Agreement with Massachusetts General Hospital 20
Boehringer Ingelheim Enters into Research Agreement with Icahn School of Medicine, Massachusetts General Hospital, Scripps Research Institute and Weill Cornell Medicine 21
Cynata Therapeutics Enters into Agreement with Massachusetts General Hospital 23
Sernova Enters into Research Agreement with Massachusetts General Hospital 24
MagnaChip Enters into Research Agreement with MGH and Pohang University for Magnetic Bio-Sensor 25
Aria Neurosciences Enters into Partnership with Massachusetts General Hospital 26
Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery 27
Sanofi Enters Into R&D Agreement With Massachusetts General Hospital For Translational Oncology Research 29
Skinmedica Enters Into R&D Agreement With Massachusetts General Hospital 30
Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 31
ZELTIQ Aesthetics Enters Into Co-Development Agreement With Massachusetts General Hospital 32
Angion Biomedica Enters Into Co-Development Agreement With Duke University And Massachusetts General Hospital 33
Veridex Enters Into Co-Development Agreement With Massachusetts General Hospital 34
Editas Medicine Enters into Second Licensing Agreement with Massachusetts General Hospital 35
Editas Medicine Enters into Licensing Agreement with Massachusetts General Hospital 36
Biohaven Pharma Enters into Licensing Agreement with General Hospital 37
Translational Sciences Enters Into Licensing Agreement with Massachusetts General Hospital & Harvard University 38
ProQR Therapeutics Enters into Licensing Agreement with Massachusetts General Hospital 39
Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 40
PTC Therapeutics Enters into Licensing Agreement with Massachusetts General Hospital 41
Columbia Labs Enters into Licensing Agreement for IVR Technology 42
NanoString Technologies Enters Into Option For Licensing Agreement With Massachusetts General Hospital 43
MultiVir Enters into Licensing Agreement with Massachusetts General Hospital 44
RetroSense Therapeutics to Enter into Licensing Agreement with Massachusetts General Hospital 45
AZTherapies Enters into Licensing Agreement with Massachusetts General Hospital 46
Santaris Pharma Enters Into Licensing Agreement With Massachusetts General Hospital 47
Massachusetts General Hospital, Key Competitors 48
Massachusetts General Hospital, Key Employees 49
Massachusetts General Hospital, Subsidiaries 50
Massachusetts General Hospital, Joint Venture 50
List of Figures
Massachusetts General Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Massachusetts General Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Massachusetts General Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Massachusetts General Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Massachusetts General Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Massachusetts General Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 8
Massachusetts General Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Massachusetts General Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
Massachusetts General Hospital, Medical Devices Deals, 2011 to YTD 2017 12
